Resveratrol integrates metabolic and growth effects in PC3 prostate cancer cells‑involvement of prolyl hydroxylase and hypoxia inducible factor‑1

Fonseca,Joao; Moradi,Fereshteh; Maddalena,Lucas A.; Ferreira‑Tollstadius,Bruna; Selim,Shehab; Stuart,Jeffrey A.

doi:10.3892/ol.2018.9526

Resveratrol integrates metabolic and growth effects in PC3 prostate cancer cells‑involvement of prolyl hydroxylase and hypoxia inducible factor‑1

Authors:
- Joao Fonseca
- Fereshteh Moradi
- Lucas A. Maddalena
- Bruna Ferreira‑Tollstadius
- Shehab Selim
- Jeffrey A. Stuart
View Affiliations

Affiliations: Department of Biological Sciences, Brock University, St. Catharines, ON L2S 3A1, Canada, MRC Cancer Research Centre, University of Cambridge, Hutchison/MRC Research Centre, Cambridge CB2 0XZ, United Kingdom, School of Medicine, University of Ottawa, Ottawa, ON K1N 6N5, Canada
Published online on: September 28, 2018 https://doi.org/10.3892/ol.2018.9526
Pages: 697-705

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Resveratrol (RES) is a polyphenol produced by certain plant species that has been well studied due to its ability to slow the growth of cancer cells. In numerous cell types and tissues, RES has been demonstrated to promote mitochondrial biogenesis, fusion, and oxidative phosphorylation. The present study investigated the interaction between RES's effects on growth and metabolism in PC3 prostate cancer cells, and demonstrated that RES‑mediated growth inhibition is only observed under conditions in which a metabolic shift from glucose fermentation to mitochondrial respiration can occur. When this shift was prevented by growing cells in galactose medium or by pharmacologically inhibiting prolyl hydroxylase (PHD) in order to stabilize hypoxia inducible factor‑1α, RES did not effect mitochondrial fusion, biogenesis, respiration or cell growth. Similar results were observed in PC3 cells expressing a mutant HIF‑1α lacking the prolines that are hydroxylated by PHD to promote its degradation. Thus, RES appears to slow PC3 cell growth by interfering with glucose fermentation and promoting respiration. Consistent with this, RES was observed to be particularly effective at inhibiting PC3 cell growth under hypoxic conditions that precluded increased reliance on oxidative phosphorylation. These observations are important in understanding how RES may affect cancer cell growth in vivo where hypoxia is common in growing tumours.

View Figures

View References

1	Diaz-Ruiz R, Rigoulet M and Devin A: The warburg and crabtree effects: On the origin of cancer cell energy metabolism and of yeast glucose repression. Biochim Biophys Acta. 1807:568–576. 2011. View Article : Google Scholar : PubMed/NCBI
2	Pavlova NN and Thompson CB: The emerging hallmarks of cancer metabolism. Cell Metab. 23:27–47. 2016. View Article : Google Scholar : PubMed/NCBI
3	Vander Heiden MG, Cantley LC and Thompson CB: Understanding the warburg effect: The metabolic requirements of cell proliferation. Science. 324:1029–1033. 2009. View Article : Google Scholar : PubMed/NCBI
4	Koppenol WH, Bounds PL and Dang CV: Otto Warburg's contributions to current concepts of cancer metabolism. Nat Rev Cancer. 11:325–337. 2011. View Article : Google Scholar : PubMed/NCBI
5	Fantin VR, St-Pierre J and Leder P: Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell. 9:425–434. 2006. View Article : Google Scholar : PubMed/NCBI
6	Le A, Cooper CR, Gouw AM, Dinavahi R, Maitra A, Deck LM, Royer RE, Vander Jagt DL, Semenza GL and Dang CV: Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression. Proc Natl Acad Sci USA. 107:2037–2042. 2010. View Article : Google Scholar : PubMed/NCBI
7	Greer SN, Metcalf JL, Wang Y and Ohh M: The updated biology of hypoxia-inducible factor. EMBO J. 31:2448–2460. 2012. View Article : Google Scholar : PubMed/NCBI
8	Masoud GN and Li W: HIF-1α pathway: Role, regulation and intervention for cancer therapy. Acta Pharm Sin B. 5:378–389. 2015. View Article : Google Scholar : PubMed/NCBI
9	Han G, Xia J, Gao J, Inagaki Y, Tang W and Kokudo N: Anti-tumor effects and cellular mechanisms of resveratrol. Drug Discov Ther. 9:1–12. 2015. View Article : Google Scholar : PubMed/NCBI
10	Stuart JA and Robb EL: Bioactive polyphenols from wine grapes. Springer Press; New York, NY: pp. 772013
11	Robb EL, Moradi F, Maddalena LA, Valente AJF, Fonseca J and Stuart JA: Resveratrol stimulates mitochondrial fusion by a mechanism requiring mitofusin-2. Biochem Biophys Res Commun. 485:249–254. 2017. View Article : Google Scholar : PubMed/NCBI
12	de Oliveira MR, Nabavi SF, Manaya A, Daglia M, Hajheydari Z and Nabavi SM: Resveratrol and the mitochondria: From triggering the intrinsic apoptotic pathway to inducing biogenesis, a mechanistic view. Biochim Biophys Acta. 1860:727–745. 2016. View Article : Google Scholar : PubMed/NCBI
13	Zhang Q, Tang X, Lu QY, Zhang ZF, Brown J and Le AD: Resveratrol inhibits hypoxia-induced accumulation of hypoxia-inducible factor-1alpha and VEGF expression in human tongue squamous cell carcinoma and hepatoma cells. Mol Cancer Ther. 4:1465–1474. 2005. View Article : Google Scholar : PubMed/NCBI
14	Zhang M, Li W, Yu L and Wu S: The suppressive effect of resveratrol on HIF-1α and VEGF expression after warm ischemia and reperfusion in rat liver. PLoS One. 9:e1095892014. View Article : Google Scholar : PubMed/NCBI
15	Rossignol R, Gilerson R, Aggeler R, Yamagata K, Remington SJ and Capaldi RA: Energy substrate modulates mitochondrial structure and oxidative capacity in cancer cells. Cancer Res. 64:985–993. 2004. View Article : Google Scholar : PubMed/NCBI
16	Valente AJ, Maddalena LA, Robb EL, Moradi F and Stuart JA: A simple ImageJ macro tool for analyzing mitochondrial network morphology in mammalian cell culture. Acta Histochem. 119:315–326. 2017. View Article : Google Scholar : PubMed/NCBI
17	Huang X, Zhou J, Liu J, Tang B, Zhao F and Qu Y: Biological characteristics of prostate cancer cells are regulated by hypoxia-inducible factor 1α. Oncol Lett. 8:1217–1221. 2014. View Article : Google Scholar : PubMed/NCBI
18	Huang H, Benzonana LL, Zhao H, Watts HR, Perry NJ, Bevan C, Brown R and Ma D: Prostate cancer cell malignancy via modulation of HIF-1α pathway with isoflurane and propofol alone and in combination. Br J Cancer. 111:1338–1349. 2014. View Article : Google Scholar : PubMed/NCBI
19	Yan Q, Bartz S, Mao M, Li L and Kaelin WG Jr: The hypoxia-inducible factor 2alpha N-terminal and C-terminal transactivation domains cooperate to promote renal tumorigenesis in vivo. Mol Cell Biol. 27:2092–2102. 2007. View Article : Google Scholar : PubMed/NCBI
20	Sen A, Ren S, Lerchenmüller C, Sun J, Weiss N, Most P and Peppel K: MicroRNA-138 regulates hypoxia-induced endothelial cell dysfunction by targeting S100A1. PLoS One. 8:e786842013. View Article : Google Scholar : PubMed/NCBI
21	Muz B, de la Puente P, Azab F and Azab AK: The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy. Hypoxia (Auckl). 3:83–92. 2015. View Article : Google Scholar : PubMed/NCBI
22	Hirschey MD, DeBerardinis RJ, Diehl AME, Drew JE, Frezza C, Green MF, Jones LW, Ko YH, Le A, Lea MA, et al: Dysregulated metabolism contributes to oncogenesis. Semin Cancer Biol. 35 Suppl:S129–S150. 2015. View Article : Google Scholar : PubMed/NCBI
23	Amoedo ND, Obre E and Rossignol R: Drug discovery strategies in the field of tumor energy metabolism: Limitations by metabolic flexibility and metabolic resistance to chemotherapy. Biochim Biophys Acta Bioenerg. 1858:674–685. 2017. View Article : Google Scholar : PubMed/NCBI
24	Kankotia S and Stacpoole PW: Dichloroacetate and cancer: New home for an orphan drug? Biochim Biophys Acta. 1846:617–629. 2014.PubMed/NCBI
25	Holden HM, Rayment I and Thoden JB: Structure and function of enzymes of the Leloir pathway for galactose metabolism. J Biol Chem. 278:43885–43888. 2003. View Article : Google Scholar : PubMed/NCBI
26	Robb EL and Stuart JA: The stilbenes resveratrol, pterostilbene and piceid affect growth and stress resistance in mammalian cells via a mechanism requiring estrogen receptor beta and the induction of Mn-superoxide dismutase. Phytochemistry. 98:164–173. 2014. View Article : Google Scholar : PubMed/NCBI
27	Courtnay R, Ngo DC, Malik N, Ververis K, Tortorell SM and Kargiannis TC: Cancer metabolism and the Warburg effect: The role of HIF-1 and PI3K. Mol Biol Rep. 42:841–851. 2015. View Article : Google Scholar : PubMed/NCBI
28	Boulahbel H, Durán RV and Gottlieb E: Prolyl hydroxylases as regulators of cell metabolism. Biochem Soc Trans. 37:291–294. 2009. View Article : Google Scholar : PubMed/NCBI
29	Jokilehto T and Jaakola PM: The role of HIF prolyl hydroxylases in tumour growth. J Cell Mol Med. 14:758–770. 2010. View Article : Google Scholar : PubMed/NCBI
30	Nguyen TL and Durán RV: Prolyl hydroxylase domain enzymes and their role in cell signaling and cancer metabolism. Int J Biochem Cell Biol. 80:71–80. 2016. View Article : Google Scholar : PubMed/NCBI
31	Li G, Rivas P, Bedolla R, Thapa D, Reddick RL, Ghosh R and Kumar AP: Dietary resveratrol prevents development of high-grade prostatic intraepithelial neoplastic lesions: Involvement of SIRT1-S6K axis. Cancer Prev Res (Phila). 6:27–39. 2013. View Article : Google Scholar : PubMed/NCBI
32	Chen L, Shi Y, Yuan J, Han Y, Qin R, Wu Q, Jia B, Wei B, Wei L, Dai G and Jiao S: HIF-1 alpha overexpression correlates with poor overall survival and disease-free survival in gastric cancer patients post-gastrectomy. PLoS One. 9:e906782014. View Article : Google Scholar : PubMed/NCBI